Second Circuit grapples with “transparency” in Vitamin C rerun

A federal appellate court has queried how the Chinese government’s transparency about its legal system should impact the amount of deference it is given in defining laws that apparently mandated alleged price-fixing between vitamin makers.


Get unlimited access to all Global Competition Review content